Browse the full directors' dealings record of PROTEON THERAPEUTICS INC, a listed issuer based in United States. Shares trade on US US, under the supervision of SEC (Form 4). Market capitalisation: €791. The latest transaction was filed on 5 January 2016 (Attribution). Among the most active insiders: NOYES TIMOTHY P. Every trade is free.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
4 of 4 declarations
PROTEON THERAPEUTICS INC is a company focused on developing therapies for kidney diseases. It is listed on the NASDAQ under the symbol PTN.